[Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
Based on a case-report, drug-related problems of the therapy of a female patient with Alzheimer's disease are discussed. According to the SOAP scheme options for optimizing the pharmacotherapy are discussed.
Schwalbe
Oliver
O
Martin-Luther-Universität Halle-Wittenberg, FB Pharmazie, Abt. Klin. Pharmazie, Wolfgang-Langenbeck-Str. 4, 06120 Halle.
Wunderlich
Silke
S
Kloft
Charlotte
C
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D004347:Drug Interactions; D005260:Female; D005702:Galantamine / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D018697:Nootropic Agents / Q000009:adverse effects* / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D005702:Galantamine